THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 84 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $577,000 | +42.5% | 22,290 | +7.2% | 0.03% | +40.0% |
Q3 2019 | $405,000 | +5.5% | 20,790 | +38.6% | 0.02% | -20.0% |
Q4 2018 | $384,000 | +14.3% | 15,005 | +45.6% | 0.02% | +66.7% |
Q3 2018 | $336,000 | +9.4% | 10,306 | -24.0% | 0.02% | +25.0% |
Q2 2018 | $307,000 | -55.8% | 13,561 | -74.6% | 0.01% | -47.8% |
Q2 2015 | $694,000 | -22.3% | 53,379 | -10.9% | 0.02% | -30.3% |
Q4 2014 | $893,000 | – | 59,885 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |